Skip to main content
Figure 4 | BMC Immunology

Figure 4

From: Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals

Figure 4

Changes in CD4+T cell counts within 1 to 5 months of receiving the ASO3-adjuvanted A/California/07/09 H1N1 influenza HA vaccine for HIV-infected responders and non-responders (a). In panel b, the changes in CD4+ T cell counts of individuals whose HIV virus load changed by > 1 log10 over the observation period were excluded from analysis. Lines within groups represent group median with IQR and the p value indicating probability of no significant difference between groups is shown above a line spanning the groups.

Back to article page